Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
1(10%)
Results Posted
25%(1 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_3
3
30%
Ph phase_2
3
30%
Ph phase_1
3
30%
Ph not_applicable
1
10%

Phase Distribution

3

Early Stage

3

Mid Stage

3

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
3(30.0%)
Phase 2Efficacy & side effects
3(30.0%)
Phase 3Large-scale testing
3(30.0%)
N/ANon-phased studies
1(10.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)
Other(4)

Detailed Status

Completed4
unknown4
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (30.0%)
Phase 23 (30.0%)
Phase 33 (30.0%)
N/A1 (10.0%)

Trials by Status

completed440%
unknown440%
recruiting110%
terminated110%

Recent Activity

1 active trials
Showing 5 of 10
recruitingphase_1

Donation of Whole Blood by Healthy Volunteers After Mobilisation by Haematopoietic Growth Factor (Rhu-G-CSF = Granocyte)

NCT05594433
terminatedphase_2

A Phase II Study Evaluating Intravenous Melphalan With Autologous Whole Blood Stem Cell Transplantation Over Three Cycles In Patients With Castration-Resistant Prostate Cancer (MEL-CAP)

NCT01907009
completedphase_2

Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine

NCT01180322
completedphase_3

Azacytidine (Vidaza®) Versus Fludarabine and Cytarabine (Fluga Scheme) in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT02319135
unknownnot_applicable

Efficacy of Granulocyte-Colony Stimulating Factor (G-CSF)

NCT03498248
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT05594433Phase 1

Donation of Whole Blood by Healthy Volunteers After Mobilisation by Haematopoietic Growth Factor (Rhu-G-CSF = Granocyte)

Recruiting
NCT01907009Phase 2

A Phase II Study Evaluating Intravenous Melphalan With Autologous Whole Blood Stem Cell Transplantation Over Three Cycles In Patients With Castration-Resistant Prostate Cancer (MEL-CAP)

Terminated
NCT01180322Phase 2

Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine

Completed
NCT02319135Phase 3

Azacytidine (Vidaza®) Versus Fludarabine and Cytarabine (Fluga Scheme) in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Completed
NCT03498248Not Applicable

Efficacy of Granulocyte-Colony Stimulating Factor (G-CSF)

Unknown
NCT00379574Phase 1

Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL

Completed
NCT00551122Phase 1

Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors

Unknown
NCT00499018Phase 3

Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma

Unknown
NCT01085058Phase 2

Predictive Value of the "Cytocapacity Test" Patients With Lymphoproliferative Diseases and High-dose Therapy

Completed
NCT00932217Phase 3

Study on the Incidence of Febrile Episodes During Stem Cells Collection After Chemotherapy in Patients With Multiple Myeloma

Unknown

All 10 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
10